Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Labreuche

Showing results (71-80 of 448) with videos related to

Pageof 45
Sort By:
BMJ Open|May 21, 2020
Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel diseaseJérémy Vanhelst, Stéphanie Coopman, Julien Labreuche, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 12, 2015
Predictors of functional outcomes and recurrence of chronic subdural hematomasHenri-Arthur Leroy, Rabih Aboukaïs, Nicolas Reyns, et al.
Allergy|January 13, 2019
Food-related anaphylaxis fatalities: Analysis of the Allergy Vigilance Network<sup>®</sup> databaseGuillaume Pouessel, Etienne Beaudouin, Luciana K Tanno, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Impact of White Matter Hyperintensity Volume on Prognosis After Mechanical Thrombectomy in Ischemic Stroke PatientsThéo Hancer, Maéva Kyheng, Julien Labreuche, et al.
Drug Safety|December 19, 2016
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in FranceMarine Auffret, Julien Labreuche, Alain Duhamel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2005
Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular diseaseElise Lavergne, Julien Labreuche, Mehdi Daoudi, et al.
Stroke|April 23, 2019
Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral HemorrhageBarbara Casolla, Solène Moulin, Maéva Kyheng, et al.
European Urology Open Science|July 11, 2022
Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted BiopsyThomas Bommelaere, Arnauld Villers, Philippe Puech, et al.
Drug Safety|February 12, 2017
Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''Marine Auffret, Julien Labreuche, Alain Duhamel, et al.
Diabetes & Metabolism|December 21, 2021
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complicationsFloriane Barbry, Madleen Lemaitre, Camille Ternynck, et al.
Pageof 45

Showing results (71-80 of 448) with videos related to

Sort By:
Pageof 45
BMJ Open|May 21, 2020
Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel diseaseJérémy Vanhelst, Stéphanie Coopman, Julien Labreuche, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 12, 2015
Predictors of functional outcomes and recurrence of chronic subdural hematomasHenri-Arthur Leroy, Rabih Aboukaïs, Nicolas Reyns, et al.
Allergy|January 13, 2019
Food-related anaphylaxis fatalities: Analysis of the Allergy Vigilance Network<sup>®</sup> databaseGuillaume Pouessel, Etienne Beaudouin, Luciana K Tanno, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Impact of White Matter Hyperintensity Volume on Prognosis After Mechanical Thrombectomy in Ischemic Stroke PatientsThéo Hancer, Maéva Kyheng, Julien Labreuche, et al.
Drug Safety|December 19, 2016
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in FranceMarine Auffret, Julien Labreuche, Alain Duhamel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 2005
Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular diseaseElise Lavergne, Julien Labreuche, Mehdi Daoudi, et al.
Stroke|April 23, 2019
Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral HemorrhageBarbara Casolla, Solène Moulin, Maéva Kyheng, et al.
European Urology Open Science|July 11, 2022
Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted BiopsyThomas Bommelaere, Arnauld Villers, Philippe Puech, et al.
Drug Safety|February 12, 2017
Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''Marine Auffret, Julien Labreuche, Alain Duhamel, et al.
Diabetes & Metabolism|December 21, 2021
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complicationsFloriane Barbry, Madleen Lemaitre, Camille Ternynck, et al.
Pageof 45